Volume | 1,423,724 |
|
|||||
News | - | ||||||
Day High | 77.25 | Low High |
|||||
Day Low | 75.38 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
75.77 | 75.38 | 77.25 | 76.28 | 75.77 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
26,809 | 1,423,724 | US$ 76.23 | US$ 108,533,600 | - | 64.02 - 87.88 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:20:00 | formt | 4,074 | US$ 76.28 | USD |
Hologic (HOLX) Options Flow Summary
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
17.9B | 234.73M | - | 4.05B | 456M | 1.94 | 39.26 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 76.76 | 77.38 | 75.14 | 76.08 | 1,056,364 | -0.48 | -0.63% |
1 Month | 76.85 | 79.22 | 74.53 | 76.70 | 1,450,729 | -0.57 | -0.74% |
3 Months | 74.55 | 79.22 | 72.50 | 75.63 | 1,655,175 | 1.73 | 2.32% |
6 Months | 66.25 | 79.22 | 65.55 | 73.24 | 1,804,333 | 10.03 | 15.14% |
1 Year | 85.80 | 87.88 | 64.02 | 74.57 | 1,741,623 | -9.52 | -11.10% |
3 Years | 65.53 | 87.88 | 59.78 | 73.23 | 1,730,869 | 10.75 | 16.40% |
5 Years | 46.31 | 87.88 | 26.49 | 65.60 | 1,900,600 | 29.97 | 64.72% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |